IP Library Granted Patent US 12,474,347
Granted Patent B2
US 12,474,347 · App. 18/887,759 · Granted Nov 18, 2025

Determination of protein information by recoding amino acid polymers into DNA polymers

Inventors: Michael Graige (San Diego, CA); Christopher MacDonald (San Diego, CA)
Assignee: ABRUS BIO, INC.
G01N33/6824C12Q1/6851G01N33/5308G01N33/552
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,474,347
App. No.
18/887,759
Granted
Nov 18, 2025
Kind
B2
Abstract

The present disclosure relates to compositions of matter, methods, and systems for analyzing polymeric macromolecules, including polymeric macromolecules such as peptides, polypeptides, and proteins.

Claims (36)

1 . A chemically-reactive conjugate (CRC) represented by Formula I:

wherein A comprises a nucleic acid cycle tag indicative of a workflow cycle, B comprises a reactive moiety that covalently binds and cleaves an N-terminal amino acid from a polypeptide, C comprises an immobilizing moiety, L A comprises a bond or linker, L B , comprises a bond or linker, L C comprises a bond or linker,

comprises a central moiety, and A, B and C are covalently connected to the central moiety through L A , L B , and L C .

2 . The CRC of claim 1 , comprising a cleavable group between (A) and (B), between (B) and (C), between (A) and (C), between (A) and (B+C), between (B) and (A+C), or between (C) and (A+B), or any combination thereof.

3 . The CRC of claim 1 , wherein the reactive moiety comprises a phenyl isothiocyanate, an isothiocyanate, a dansyl chloride, a dinitrofluorobenzene, an enzyme or peptide, or a combination or derivative thereof.

4 . The CRC of claim 1 , wherein the immobilizing moiety comprises a protected thiol group, a protected amine group, or a carboxyl group, an azide, an alkyne, an alkene, an aryl boronic acid, an aryl halide, a haloalkyne, an acryl, a silylalkyne, a Si—H group, a protected or photoprotected reactive group, or a photoactivated reactive group.

5 . The CRC of claim 1 , wherein the nucleic acid cycle tag is generated upon conjugating a nucleic acid sequence to a group comprising a protected or unprotected oxyamine group, a protected or unprotected thiol, a protected or unprotected amine, a protected or unprotected hydrazine, a tetrazine, an azide, an alkyne, an alkene, a trans-cyclooctene, a dibenzocyclooctyne, a bicyclononyne, a norbornene, a strained alkyne, or a strained alkene, or a derivative thereof.

6 . The CRC of claim 1 , wherein the N-terminal amino acid is derivatized and comprises a tetrazine, an azide, an alkene, an alkyne, a trans-cyclooctene, a dibenzocyclooctyne, a bicyclononyne, a norbornene, a strained alkyne, or a strained alkene.

7 . A chemically-reactive conjugate (CRC) represented by Formula II:

A

-

L

AB

B

-

L

BC

C

,

(

Formula

II

)

(Formula II), wherein at least one of A, B and C comprises a nucleic acid cycle tag indicative of a workflow cycle, at least one of A, B and C comprises a reactive moiety that covalently binds and cleaves an N-terminal amino acid from a polypeptide, at least one of A, B and C comprises an immobilizing moiety, L AB comprises a bond or linker, L BC comprises a bond or linker, and A, B and C are covalently connected through L AB and L BC .

8 . The CRC of claim 7 , comprising a cleavable group between (A) and (B), between (B) and (C), or a combination thereof.

9 . The CRC of claim 7 , wherein the reactive moiety comprises a phenyl isothiocyanate, an isothiocyanate, a dansyl chloride, a dinitrofluorobenzene, an enzyme or peptide, or a combination or derivative thereof.

10 . The CRC of claim 7 , wherein the immobilizing moiety comprises a protected thiol group, a protected amine group, or a carboxyl group, an azide, an alkyne, an alkene, an aryl boronic acid, an aryl halide, a haloalkyne, an acryl, a silylalkyne, a Si—H group, a protected or photoprotected reactive group, or a photoactivated reactive group.

11 . The CRC of claim 7 , wherein the nucleic acid cycle tag is generated upon conjugating a the nucleic acid sequence to a group comprising a protected or unprotected oxyamine group, a protected or unprotected thiol, a protected or unprotected amine, a protected or unprotected hydrazine, a tetrazine, an azide, an alkyne, an alkene, a trans-cyclooctene, a dibenzocyclooctyne, a bicyclononyne, a norbornene, a strained alkyne, or a strained alkene, or a derivative thereof.

12 . The CRC of claim 7 , wherein the N-terminal amino acid is derivatized and comprises a tetrazine, an azide, an alkene, an alkyne, a trans-cyclooctene, a dibenzocyclooctyne, a bicyclononyne, a norbornene, a strained alkyne, or a strained alkene.

13 . The CRC of claim 1 , wherein the nucleic acid sequence cycle-tag comprises a peptide nucleic acid.

14 . The CRC of claim 1 , wherein L A , L B and L C comprise polyethylene glycol, hydrocarbon, ether, carboxyl, amine, amide, azide, thiol, azide-thiol, alkylene, heteroalkylene, cyclic, or phenyl linkers.

15 . The CRC of claim 1 , wherein the reactive moiety comprises a phenyl isothiocyanate, isothiocyanate, dansyl chloride, or dinitrofluorobenzene.

16 . The CRC of claim 7 , wherein the nucleic acid cycle tag comprises a peptide nucleic acid.

17 . The CRC of claim 7 , wherein L AB and L BC comprise polyethylene glycol, hydrocarbon, ether, carboxyl, amine, amide, azide, thiol, azide-thiol, alkylene, heteroalkylene, cyclic, or phenyl linkers.

18 . The CRC of claim 7 , wherein the reactive moiety comprises a phenyl isothiocyanate, isothiocyanate, dansyl chloride, or dinitrofluorobenzene.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2025
From: GRAIGE, MICHAEL; MACDONALD, CHRIS
To: ABRUS BIO, INC.
Reel/Frame 070617/0338 →
Continuity (6)
Continuation PCTUS2023072498 · Aug 18, 2023
Continuation PCTUS2023070077 · Jul 12, 2023
Provisional Application 63467729 · May 19, 2023
Provisional Application 63439523 · Jan 17, 2023
Provisional Application 63399294 · Aug 19, 2022
Related Publication 20250020657A1 · Jan 16, 2025
References Cited (80)
US 7611834B2 · Chhabra et al. · 2009 [cited by applicant]
US 10287576B2 · Franch et al. · 2019 [cited by applicant]
US 10697974B2 · Woo et al. · 2020 [cited by applicant]
US 10852305B2 · Havranek et al. · 2020 [cited by applicant]
US 11118215B2 · Thisted et al. · 2021 [cited by applicant]
US 11499979B2 · Estandian et al. · 2022 [cited by applicant]
US 11513126B2 · Chee et al. · 2022 [cited by applicant]
US 12038443B2 · Graige et al. · 2024 [cited by applicant]
US 12188940B2 · Graige et al. · 2025 [cited by applicant]
US 20140273004A1 · Havranek et al. · 2014 [cited by applicant]
US 20200348307A1 · Beierle et al. · 2020 [cited by applicant]
US 20200385432A1 · Tullman et al. · 2020 [cited by applicant]
US 20210079557A1 · Pawlosky et al. · 2021 [cited by applicant]
US 20210147474A1 · Dyer et al. · 2021 [cited by applicant]
US 20220348990A1 · Kishi et al. · 2022 [cited by applicant]
US 20230016396A1 · Gunderson et al. · 2023 [cited by applicant]
US 20230107647A1 · Marcotte et al. · 2023 [cited by applicant]
US 20230193248A1 · Suastegui et al. · 2023 [cited by applicant]
US 20230203562A1 · Okerberg et al. · 2023 [cited by applicant]
US 20230220589A1 · Gunderson et al. · 2023 [cited by applicant]
US 20230236198A1 · Chee et al. · 2023 [cited by applicant]
US 20230305017A1 · Estandian et al. · 2023 [cited by applicant]
US 20240044909A1 · Graige et al. · 2024 [cited by applicant]
US 20240158829A1 · Chee et al. · 2024 [cited by applicant]
US 20240210410A1 · Graige et al. · 2024 [cited by applicant]
AU 2018204665B2 · 2020 [cited by applicant]
WO 2010065322A1 · 2010 [cited by applicant]
WO 2017192633A1 · 2017 [cited by applicant]
WO 2019089836A1 · 2019 [cited by applicant]
WO 2019089851A1 · 2019 [cited by applicant]
WO 2020146325A1 · 2020 [cited by applicant]
WO 2021236716A2 · 2021 [cited by applicant]
WO 2022015600A2 · 2022 [cited by applicant]
WO 2022132188A1 · 2022 [cited by applicant]
WO 2023019148A1 · 2023 [cited by applicant]
WO 2023019163A1 · 2023 [cited by applicant]
WO 2023114732A2 · 2023 [cited by applicant]
WO 2023122698A1 · 2023 [cited by applicant]
WO 2023196642A1 · 2023 [cited by applicant]
WO 2024015875A2 · 2024 [cited by applicant]
WO 2024040236A2 · 2024 [cited by applicant]
WO 2024107755A1 · 2024 [cited by applicant]
WO 2024159162A1 · 2024 [cited by applicant]
4-Azidophenyl Isothiocyanate, Bench Chem, Retrieved on Apr. 4, 2024, 13 Pages. [cited by applicant]
International Application No. PCT/US2023/070077, Protein recoding & sequencing, filed on Jul. 12, 2023, 1 page. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2023/072498, mailed on Mar. 15, 2024, 19 pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2023/070077, mailed on Jan. 23, 2024, 14 pages. [cited by applicant]
(2018) Safety Data Sheet, Axis Pharm, 1 page. [cited by applicant]
Bailey et al. (Jan. 1992) “Automated Carboxy-Terminal Sequence Analysis of Peptides”, Protein Science, 1(1):68-80. [cited by applicant]
Borgo et al. (Apr. 2015) “Computer-aided Design of a Catalyst for Edman Degradation Utilizing Substrate-assisted Catalysis”, Protein Science, 24(4):571-579. [cited by applicant]
Chelius et al. (2003) “Capture of Peptides with N-Terminal Serine and Threonine: A Sequence-Specific Chemical Method for Peptide Mixture Simplification”, Bioconjugate Chemistry, 14(1):205-211. [cited by applicant]
Crook et al. (Apr. 2022) “Challenges and Opportunities for Bayesian Statistics in Proteomics”, Journal of Proteome Research, 21(4):849-864. [cited by applicant]
Database Genbank. “Aminopeptidase From Aeromonasproteolytic A”, CAS No. 37288-67-8, Retrieved on Sep. 19, 2023, 2 pages. [cited by applicant]
Database Genbank, “Product information “Amino-Modifier CG dT””, CAS No. 178925-21-8, Retrieved on Sep. 18, 2023, 4 pages. [cited by applicant]
Davis et al. (Jun. 2013) “DNA Double Strand Break Repair via Non-Domologous End-Joining”, Translational Cancer Research, 2(3):130-143 (19 pages). [cited by applicant]
Dupont et al. (2000) “The Alkylated Thiohydantoin Method for C-Terminal Sequence Analysis”. EXS, 88:119-131. [cited by applicant]
Gee et al. (1998) “Synthesis, Photochemistry, and Biological Characterization of Photolabile Protecting Groups for Carboxylic Acids and Neurotransmitters”, Methods in Enzymology, 291:30-50. [cited by applicant]
Grzybowski et al. (1993) “Synthesis and Antibody-mediated Detection of Oligonucleotides Containing Multiple 2,4-dinitrophenyl Reporter Groups”, Nucleic Acids Res, 21(8):1705-1712. [cited by applicant]
Gunderson et al. (2004) “Decoding Randomly Ordered DNA Arrays”, Genome Research, 14:870-877. [cited by applicant]
Hong et al. (2009) “Analysis and Optimization of Copper-catalyzed Azide-Alkyne Cycloaddition for Bioconjugation”, Angewandte Chemie, 48(52):9879-9883. [cited by applicant]
Klayman et al. (1979) “2-Acetylpyridine Thiosemicarbazones. 2. N4, N4-Disubstituted Derivatives as Potential Antimalarial Agents”, Journal of Medicinal Chemistry, 22(11):1367-1373. [cited by applicant]
Kluger et al. (2004) “Chemical Cross-Linking and Protein-Protein Interactions—A Review with Illustrative Protocols”, Bioorganic chemistry, 32(6):451-472. [cited by applicant]
Knall et al. (Oct. 20, 2016) “A Trifunctional Linker Suitable for Conducting Three Orthogonal Click Chemistries in One Pot”, Organic & Biomolecular Chemistry, 14:10576-10580. [cited by applicant]
Laursen et al. (1977) “Coupling Methods and Strategies in Solid-Phase Sequencing”, Advanced Methods in Protein Sequence Determination, 21-37. [cited by applicant]
Lohman et al. (2016) “A High-Throughput Assay for the Comprehensive Profiling of DNA Ligase Fidelity”, Nucleic Acids Research, 44(2):e14 (11 pages). [cited by applicant]
Muller, Manuel M. (Jan. 16, 2018) “Post-Translational Modifications of Protein Backbones: Unique Functions, Mechanisms, and Challenges”, Biochemistry, 57(2):177-185. [cited by applicant]
Okuno et al. (Jun. 27. 2000) “Folding Character of Cytochrome c Studied by o-Nitrobenzyl Modification of Methionine 65 and Subsequent Ultraviolet Light Irradiation”, Biochemistry, 39(25):7538-7545. [cited by applicant]
Palmiero et al. (Aug. 19, 2016) “The RAFT Copolymerization of Acrylic Acid and Acrylamide”, Polymer, 98:156-164. [cited by applicant]
Pirrung et al. (Dec. 1992) “Synthesis of Photodeprotectable Serine Derivatives. “Caged Serine””, Bioorganic & Medicinal Chemistry Letters, 2(12):1489-1492. [cited by applicant]
Presolski et al. (Dec. 1, 2011) “Copper-Catalyzed Azide-Alkyne Click Chemistry for Bioconjugation”, Current Protocols in Chemical Biology, 3(4):153-162. [cited by applicant]
Raza et al. (Jan. 18, 2018) “A Review on Recent Advances in Stabilizing Peptides/Proteins upon Fabrication in Hydrogels from Biodegradable Polymers”, Pharmaceutics, 10(1):16 (21 pages). [cited by applicant]
Saiki et al. (1989) “Genetic Analysis of Amplified DNA With Immobilized Sequence-specific Oligonucleotide Probes”, Proceedings of the National Academy of Science, 86(16):6230-6234. [cited by applicant]
Shamsi et al. (Oct. 1, 2011) “Characterization of Peptide Immobilization on an Acetylene Terminated Surface Via Click Chemistry”, Surface Science, 605(19-20):1763-1770. [cited by applicant]
Shashkova et al. (2017) “Single-Molecule Fluorescence Microscopy Review: Shedding New Light on Old Problems”, Bioscience Reports, 37(4):BSR20170031 (19 pages). [cited by applicant]
Tatsu et al. (Oct. 23, 1996) “Solid-Phase Synthesis of Caged Peptides Using Tyrosine Modified with a Photocleavable Protecting Group: Application to the Synthesis of Caged Neuropeptide Y”, Biochemical and Biophysical Re… [cited by applicant]
Tatsu et al. (Aug. 19, 1999) “Synthesis of Caged Peptides Using Caged Lysine: Application to the Synthesis of Caged AIP, a Highly Specific Inhibitor of Calmodulin-dependent Protein Kinase II”, Bioorganic & Medicinal Che… [cited by applicant]
Watts et al. (Jun. 2009) “Studies on the Hydrolytic Stability of 2′-fluoroarabinonucleic Acid (2′F-ANA)”, Organic & Biomolecular Chemistry, 7(9):1904-1910. [cited by applicant]
Ionov, Leonid (Dec. 2014) “Hydrogel-based Actuators: Possibilities and Limitations”, Materials Today, 17(10):494-503. [cited by applicant]
Matsudaira, Paul (1993) “A Practical Guide to Protein and Peptide Purification for Microsequencing”, Second Edition, 104-123. [cited by applicant]
Popławski et al. (2009) “[Non-Homologous DNA End Joining—New Proteins, New Functions, New Mechanisms]”, Postpy Biochemii, Abstract, 55(1):36-45. [cited by applicant]
Cited By (1)
US 12,644,891